Organization
University of Arizona
38 clinical trials
17 abstracts
Clinical trial
CT-guided Pudendal Nerve Cryoneurolysis for Palliation of Malignancy-induced Pelvic PainStatus: Not yet recruiting, Estimated PCD: 2026-11-01
Clinical trial
Modifying Genes in Cystic Fibrosis: The Beta-2 Adrenergic Receptors and Epithelial Na+ ChannelsStatus: Completed, Estimated PCD: 2012-07-01
Clinical trial
Phase II Trial of Intravesical Gemcitabine in Patients With Nonmuscle Invasive Bladder Cancer With or Without Prior Bacillus Calmette-Guérin TherapyStatus: Recruiting, Estimated PCD: 2025-01-31
Clinical trial
Pre-operative Tamsulosin After Minimally Invasive Hysterectomy and Time to Spontaneous Void: A Randomized Controlled TrialStatus: Completed, Estimated PCD: 2023-06-24
Clinical trial
A Pilot Phase II Study Evaluating the Role of Chlorine Dioxide on Mucositis for Patients Undergoing Head and Neck RadiotherapyStatus: Terminated, Estimated PCD: 2022-11-07
Clinical trial
Pharmaco-Diagnostic Crossover Trial for Peripheral Nerve Continuity After TraumaStatus: Not yet recruiting, Estimated PCD: 2027-12-01
Clinical trial
AZithromycin Therapy in Preschoolers With a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED)Status: Recruiting, Estimated PCD: 2025-11-15
Clinical trial
Do Experience of Pain and 30-Day Surgery Outcomes Differ in Robotic Bariatric Surgery Patients Treated With Narcotic vs. Non-narcotic Pain Management Protocols?Status: , Estimated PCD: 2024-06-01
Clinical trial
Enhancing Language Function in Primary Progressive Aphasia (PPA) With Transcranial Direct Current Stimulation (tDCS)Status: Recruiting, Estimated PCD: 2025-12-30
Clinical trial
An Open-Label, Phase II Single-Arm, Window Trial of Tadalafil Effect + Chemotherapy in Patients With Resectable Gastric/GEJ AdenocarcinomaStatus: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
A Randomized, Double-blind, Placebo Controlled Study of the Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury (TBI)Status: Not yet recruiting, Estimated PCD: 2027-09-01
Clinical trial
Using Sleep Health to Optimize Smoking Cessation Treatment Response in HIV-Positive AdultsStatus: Recruiting, Estimated PCD: 2025-02-28
Clinical trial
Safety and Efficacy of Allopregnanolone (Allo) as a Regenerative Therapeutic for Alzheimer's Disease: Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Clinical TrialStatus: Recruiting, Estimated PCD: 2025-04-01
Clinical trial
M4OC-Prevent 2.0: Phase IIb Trial of Metformin for Oral Cancer PreventionStatus: Recruiting, Estimated PCD: 2026-08-31
Clinical trial
Phase II, Randomized, Investigator Initiated Trial to Evaluate Safety and to Explore Clinical Benefit of Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19)Status: Terminated, Estimated PCD: 2022-06-30
Clinical trial
Phase 2, Single Center, Single Arm Study to Evaluate the Decrease in CIPN With the Addition of Hydroxychloroquine to Chemotherapy in Patients With Early Stage (1-3) Breast Cancer and Gynecological Cancers Treated With Curative IntentStatus: Withdrawn, Estimated PCD: 2025-02-01
Clinical trial
A Single Arm Phase II Study to Evaluate Efficacy of T-DM1 With Palbociclib in the Treatment of Patients With Metastatic HER2 Positive Breast CancerStatus: Completed, Estimated PCD: 2022-12-22
Clinical trial
Window of Opportunity Trial to Evaluate Change in PD-L1 Expression in Triple Negative Breast Tumors in Response to the PARP Inhibitor RucaparibStatus: Active (not recruiting), Estimated PCD: 2024-11-30
Clinical trial
Psilocybin for Treatment of Obsessive Compulsive DisorderStatus: Active (not recruiting), Estimated PCD: 2023-10-30
Clinical trial
Double Blind Trial Investigating the Role of Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer PatientsStatus: Recruiting, Estimated PCD: 2025-01-02
Clinical trial
Fycompa Titration Intervals and Effects on Retention RateStatus: Completed, Estimated PCD: 2021-02-24
Clinical trial
Investigation of the Effectiveness of Vibratory Stimulus in Trigger Finger InjectionsStatus: Recruiting, Estimated PCD: 2025-08-01
Clinical trial
A Single Arm Phase 2 Study of Talimogene Laherparepvec in Patients With Cutaneous Squamous Cell CancerStatus: Completed, Estimated PCD: 2023-07-19
Clinical trial
Carbonic Anhydrase Inhibitors and Carbonation: A Novel Approach to Reduce Soda ConsumptionStatus: , Estimated PCD: 2024-05-01
Clinical trial
A Phase I/Ib Study of Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide and/or BendamustineStatus: Active (not recruiting), Estimated PCD: 2025-08-25
Clinical trial
Medications for Obstructive Sleep Apnea to Improve Cognition in Children With Down SyndromeStatus: Recruiting, Estimated PCD: 2025-08-01
Clinical trial
Immune Modulation by Abemaciclib in HPV-Negative Head and Neck Squamous Cell Carcinoma (HNSCC): A Randomized Phase II Window Trial.Status: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer RiskStatus: Completed, Estimated PCD: 2018-11-30
Clinical trial
A Single-center Phase I Open-label Study of the Tolerability and Efficacy of Low-dose Ketamine Infusion for Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's DiseaseStatus: Active (not recruiting), Estimated PCD: 2022-08-25
Clinical trial
Ketamine and Morphine Versus Morphine Alone for the Treatment of Acute Pain in the Emergency DepartmentStatus: Terminated, Estimated PCD: 2014-04-01
Clinical trial
A Randomized, Phase II Study of Ficlatuzumab With or Without Cetuximab in Patients With Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaStatus: Completed, Estimated PCD: 2022-03-29
Clinical trial
Emergency Treatment of Coral Snake Envenomation With AntivenomStatus: Completed, Estimated PCD: 2016-11-11
Clinical trial
Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: IV to IM Bridging StudyStatus: Active (not recruiting), Estimated PCD: 2022-12-01
Clinical trial
A Single Arm Phase II Trial to Assess Association of BRCA1 Protein Expression With Overall Response Rate in Patients With Metastatic Breast Cancer on Pegylated Liposomal DoxorubicinStatus: Terminated, Estimated PCD: 2022-12-31
Clinical trial
Phase II Trial Evaluating the Safety and Efficacy of Atezolizumab in Combination With Cabozantinib for the Treatment of Metastatic, Refractory Pancreatic CancerStatus: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy, Safety and Tolerability of ORal Bacterial EXtract for the Prevention of Wheezing Lower Respiratory Tract Illness (ORBEX)Status: Active (not recruiting), Estimated PCD: 2025-12-31
Clinical trial
Investigating the Minimum Number of Needling Required to Optimize Trigger Point Injections OutcomeStatus: , Estimated PCD: 2024-12-09
Clinical trial
Biomarker Modulation by Alpelisib (BYL719) in Transorally Resectable, HPV-Associated HNSCC: A Phase II Window TrialStatus: Terminated, Estimated PCD: 2022-05-24
Abstract
Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA).Org: University of Texas MD Anderson Cancer Center, University of Pittsburgh, Pittsburgh, PA, NRG Oncology SDMC, UPMC Hillman Cancer Center, NSABP Foundation,
Abstract
Cost-effectiveness analysis of later-line therapies for metastatic colorectal cancer (mCRC) based on a novel methodology of network meta-analysis (NMA) of survival curves.Org: The University of Arizona, Tucson, AZ, University of Arizona Cancer Center, University of Arizona, University of Arizona of Pharmacy, Department of Pharmacy Practice and Science,
Abstract
Economic evaluation for the US of durvalumab plus gemcitabine and cisplatin (DGC) in advanced biliary tract cancer (BTC).Org: Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, University of Arizona of Pharmacy, Department of Pharmacy Practice and Science,
Abstract
Patient navigation for lung cancer screening in an urban safety-net system: A pragmatic randomized clinical trial.Org: University of Texas Southwestern Medical Center, Parkland Health, University of Arizona,
Abstract
Economic evaluation for the US of relatlimab and nivolumab (RELA+NIVO) versus nivolumab (NIVO) monotherapy in untreated advanced melanoma.Org: University of Arizona, University of Arizona of Pharmacy, Department of Pharmacy Practice and Science,
Abstract
Disparity in regional recruitment across global cancer trials: A meta-analysis.Org: Creighton University School of Medicine Phoenix Regional Campus, Division of Hematology/Oncology, Department of Medicine, University Of Toledo, Mayo Clinic, Fatima Jinnah Medical University, University of Arizona,
Abstract
Source of funding and enrollment disparity in cancer clinical trials.Org: Mayo Clinic, Nishtar Medical University Multan Pakistan, Medical University of South Carolina Hollings Cancer Center, Dow Medical College, Karachi, Pakistan, King Edward Medical University,
Abstract
Hypophosphatemia and thrombocytopenia: A retrospective chart review to identify markers for prediction of CRS and ICANS in CAR T-cell therapy.Org: Department of Medicine, Icahn School of Medicine at Mount Sinai, University of Arizona, Tucson, AZ, University of Arizona Cancer Center, Department of Pediatrics & Adolescent Medicine, Queen Mary Hospital,
Abstract
Effect on in-hospital outcomes of patients with hepatocellular carcinoma on aspirin.Org: University of Arizona, Liver Institute Northwest, University of California San Francisco- Fresno, Dayanand Medical College & Hospital, Punjab Institute of Medical Sciences,
Abstract
Comparison of outcomes of Clostridium difficile infection in autologous stem cell transplant recipients compared to allogenic stem cell transplant recipients.Org: University of Arizona, Liver Institute Northwest, University of California San Francisco- Fresno, Dayanand Medical College & Hospital, Ross University School of Medicine,
Abstract
Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas.Org: Cincinnati Children's Hospital Medical Center, Department of Pediatrics & Adolescent Medicine, Queen Mary Hospital, Division of Pediatric Hematology-Oncology, Department of Pediatrics, Charles-Bruneau Cancer Center, CHU Sainte-Justine, Montreal, QC, Canada, Oncology and Bone Marrow Transplant, School of Medicine & Public Health,
Abstract
Cost-utility analyses of later-line treatments for metastatic colorectal cancer (mCRC) by network meta-analysis (NMA) approach: Conventional constant hazard ratio vs novel survival curves methodologies.Org: University of Arizona, University of Arizona Cancer Center, University of Arizona of Pharmacy, Department of Pharmacy Practice and Science,
Abstract
Comparative efficacy of later-line therapies for metastatic colorectal cancer (mCRC) using novel methods for patient survival data reconstruction and network meta-analysis (NMA) of survival curves.Org: University of Arizona of Pharmacy, Department of Pharmacy Practice and Science, University of Arizona Cancer Center, The University of Arizona, Tucson, AZ, University of Arizona,
Abstract
Effect on hospital outcomes of hematopoietic stem cell transplant recipients with Clostridium difficile infection.Org: University of Arizona, Liver Institute Northwest, University of California San Francisco- Fresno, Dayanand Medical College & Hospital, Ross University School of Medicine,
Abstract
ADVANCE PROFILING OF ANTI-RHEUMATIC THERAPIES TRIAL: FEASIBILITY AND USE OF TOUCHSCREEN COMPUTERS FOR PATIENT REPORTED OUTCOMES (PROS)Org: Arizona Arthritis Center, University of Arizona, Tucson, AZ, Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, Arthritis Associates of S. Florida, Delray Beach,
Abstract
A COST-EFFICACY COMPARISON OF ADALIMUMAB AND ETANERCEPT IN THE TREATMENT OF RHEUMATOID ARTHRITISOrg: College of Pharmacy, Tehran University of Medical Sciences, University of Arizona, Global Health Outcomes Assessment, Wyeth Research, St Davids PA,
Abstract
A COST-EFFICACY COMPARISON OF BIOLOGIC AGENTS IN THE TREATMENT OF RHEUMATOID ARTHRITISOrg: Health Economics and Health Services Research, Zynx Health-Cerner Corporation, Beverly Hills Cancer Care, Pharmacoeconomics and Outcomes Research Iberia (PORIB), Madrid, Spain, Amgen,